IL150286A0 - Treatment of dna viral infections - Google Patents

Treatment of dna viral infections

Info

Publication number
IL150286A0
IL150286A0 IL15028600A IL15028600A IL150286A0 IL 150286 A0 IL150286 A0 IL 150286A0 IL 15028600 A IL15028600 A IL 15028600A IL 15028600 A IL15028600 A IL 15028600A IL 150286 A0 IL150286 A0 IL 150286A0
Authority
IL
Israel
Prior art keywords
treatment
viral infections
dna viral
dna
useful
Prior art date
Application number
IL15028600A
Other languages
English (en)
Original Assignee
Henderson Morley Res & Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930811.6A external-priority patent/GB9930811D0/en
Priority claimed from GB0000683A external-priority patent/GB0000683D0/en
Priority claimed from GB0023198A external-priority patent/GB0023198D0/en
Application filed by Henderson Morley Res & Dev Ltd filed Critical Henderson Morley Res & Dev Ltd
Publication of IL150286A0 publication Critical patent/IL150286A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Eyeglasses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15028600A 1999-12-30 2000-12-13 Treatment of dna viral infections IL150286A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9930811.6A GB9930811D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment
GB0000683A GB0000683D0 (en) 1999-10-15 2000-01-12 Antiviral treatment
GB0023198A GB0023198D0 (en) 1999-12-30 2000-09-21 Treatment of DNA viral infections
PCT/GB2000/004793 WO2001049242A2 (en) 1999-12-30 2000-12-13 Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside

Publications (1)

Publication Number Publication Date
IL150286A0 true IL150286A0 (en) 2002-12-01

Family

ID=27255465

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15028600A IL150286A0 (en) 1999-12-30 2000-12-13 Treatment of dna viral infections

Country Status (17)

Country Link
US (1) US6894030B2 (xx)
EP (1) EP1242119B1 (xx)
JP (1) JP2003519163A (xx)
KR (1) KR100843790B1 (xx)
CN (1) CN1414863A (xx)
AT (1) ATE261737T1 (xx)
AU (1) AU777339B2 (xx)
BR (1) BR0016831A (xx)
CA (1) CA2395016C (xx)
DE (1) DE60009146T2 (xx)
DK (1) DK1242119T3 (xx)
ES (1) ES2218254T3 (xx)
IL (1) IL150286A0 (xx)
MX (1) MXPA02006489A (xx)
PT (1) PT1242119E (xx)
TR (1) TR200401363T4 (xx)
WO (1) WO2001049242A2 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
GB2376628B (en) * 2001-06-19 2005-06-08 Henderson Morley Res & Dev Ltd Treatment of DNA viral infections in cats
GB2367242B (en) * 2000-09-21 2004-07-28 Henderson Morley Res & Dev Ltd Antiviral treatment
WO2002024207A1 (en) * 2000-09-21 2002-03-28 Henderson Morley Research & Development Limited Diuretic or sulphonylurea for use in antiviral treatment
US7534768B2 (en) * 2000-12-13 2009-05-19 Henderson Morely Research And Development Ltd. Treatment of DNA viral infections
US20060234955A1 (en) * 2002-05-28 2006-10-19 Bette Pollard Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
CA2515761C (en) 2003-02-12 2013-04-23 Georgetown University Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
WO2007047447A2 (en) * 2005-10-17 2007-04-26 Neurotherapeutics Pharma, Inc. Diuretic-like compound analogs useful for regulation of central nervous system disorders
GB0616451D0 (en) * 2006-08-18 2006-09-27 Henderson Morley Plc Dna viral infections
CN106562982A (zh) * 2016-09-27 2017-04-19 苏州系统医学研究所 强心苷类化合物在抗埃博拉病毒感染中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03240732A (ja) * 1990-02-14 1991-10-28 Yasuo Tanaka 抗ウイルス剤
US7071230B2 (en) * 1997-10-02 2006-07-04 Board Of Trustees Of Southern Illinois University Therapeutic use of D-methionine to reduce the toxicity of noise
AU5492899A (en) * 1998-08-24 2000-03-14 Hadasit Medical Research Services & Development Company Ltd The use of loop diuretics for hiv infection
AU1873101A (en) * 1999-12-30 2001-07-16 Henderson Morley Research And Development Limited Synergistic treatment of dna viral infections

Also Published As

Publication number Publication date
AU777339B2 (en) 2004-10-14
EP1242119A2 (en) 2002-09-25
AU1873401A (en) 2001-07-16
DE60009146D1 (de) 2004-04-22
DK1242119T3 (da) 2004-08-02
US6894030B2 (en) 2005-05-17
US20030050253A1 (en) 2003-03-13
DE60009146T2 (de) 2005-02-17
CA2395016A1 (en) 2001-07-12
TR200401363T4 (tr) 2004-08-23
WO2001049242A3 (en) 2002-07-11
BR0016831A (pt) 2002-09-10
KR20030005162A (ko) 2003-01-17
EP1242119B1 (en) 2004-03-17
MXPA02006489A (es) 2003-09-22
CA2395016C (en) 2009-04-14
WO2001049242A2 (en) 2001-07-12
JP2003519163A (ja) 2003-06-17
ATE261737T1 (de) 2004-04-15
ES2218254T3 (es) 2004-11-16
CN1414863A (zh) 2003-04-30
PT1242119E (pt) 2004-08-31
KR100843790B1 (ko) 2008-07-03

Similar Documents

Publication Publication Date Title
IL150286A0 (en) Treatment of dna viral infections
EP0831873A4 (en) COMBINATORY THERAPY FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS
PL308122A1 (en) Viral vectors and their application in genic therapy
HU9503605D0 (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
ZA921660B (en) Antiviral nucleoside combination
GR1003560B (el) Σκευασματα τροποποιημενης απελευθερωσης αμοξυκιλλινης και κλαβουλανικου καλιου
GR3024699T3 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections.
AU1539699A (en) Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
MD990258A (en) Method of treatment of the acute viral hepatitis B
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
AU1873101A (en) Synergistic treatment of dna viral infections
AU2001287907A1 (en) Diuretic or sulphonylurea for use in antiviral treatment
EP1032266A4 (en) USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
ES8706665A1 (es) Procedimiento de preparar nuevas sales de acidos carboxilicos, terapeuticamente utiles
CA95630S (en) Cabinet
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
HK1038697A1 (en) Treatment of chronic viral infections with m. vaccae
ZA9010337B (en) Fibroblast growth factor for use in the prevention and treatment of viral infections
MXPA02000485A (es) 2-amino-benzoxazinonas para el tratamiento del virus de herpes simple.
WO1998044913A3 (en) Compositions containing mkc-442 in combination with other antiviral agents
GB9603657D0 (en) Improvements in the treatment of vaginal infections
NZ314730A (en) Use of dideoxycytosine derivatives in the treatment of viral infection

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees